Mal-amido-PEG2-Val-Cit-PAB-PNP is a maleimide-linked PEGylated peptide ADC linker designed for stable antibody conjugation and controlled enzymatic cleavage of payloads in targeted therapy.
Structure of 2112738-13-1
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Mal-amido-PEG2-Val-Cit-PAB-PNP, a versatile linker molecule used in drug delivery and bioconjugation, plays a pivotal role in various applications.
Antibody-Drug Conjugates (ADCs): Mal-amido-PEG2-Val-Cit-PAB-PNP serves as a crucial link in the synthesis of antibody-drug conjugates. This linkage between a cytotoxic drug and an antibody ensures site-specific drug release at the tumor, minimizing systemic toxicity while maximizing therapeutic efficacy.
Controlled Drug Release: Enabling the design of advanced drug delivery systems, Mal-amido-PEG2-Val-Cit-PAB-PNP linkers provide a sophisticated approach to controlled drug release triggered by specific stimuli such as pH variations or enzymatic activity. The Val-Cit peptide sequence, susceptible to tissue-specific enzymes, allows for precise and controlled drug release at designated sites. This method enhances therapeutic efficacy while mitigating adverse effects, optimizing drug delivery for improved patient outcomes.
Pharmaceutical Research: A cornerstone of pharmaceutical research, this linker molecule facilitates exploration into the design and enhancement of drug delivery systems. Researchers leverage its flexibility to adjust properties by modifying PEG length or integrating additional functional groups, tailoring the linker for diverse therapeutic applications. This strategic customization enhances pharmacokinetic profiles and bolsters the stability of therapeutic agents, driving innovation in pharmaceutical sciences and advancing drug delivery technologies.
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-01679 | Mal-PEG2-Val-Cit-PABA-PNP | 1345681-52-8 | |
BADC-00929 | Fmoc-D-Val-Cit-PAB | 1350456-65-3 | |
BADC-00849 | Acetylene-linker-Val-Cit-PABC-MMAE | 1411977-95-1 | |
BADC-01448 | mDPR-Val-Cit-PAB-MMAE | 1491152-26-1 | |
BADC-00958 | Amino-PEG4-Val-Cit-PAB-MMAE | 1492056-71-9 | |
BADC-00708 | Val-cit-PAB-OH | 159857-79-1 | |
BADC-00968 | MC-Val-Cit-PAB | 159857-80-4 | |
BADC-00501 | Mc-Val-Cit-PABC-PNP | 159857-81-5 | |
BADC-00364 | Fmoc-Val-Cit-PAB | 159858-22-7 | |
BADC-01348 | Val-Cit-PAB-MMAE TFA salt | 1608127-32-7 |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.